Prescriber Toolkit Presentation The Care Transitions Network - - PowerPoint PPT Presentation

▶
prescriber toolkit presentation
SMART_READER_LITE
LIVE PREVIEW

Prescriber Toolkit Presentation The Care Transitions Network - - PowerPoint PPT Presentation

Apr 11, 2023 188 likes •957 views

Prescriber Toolkit Presentation The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart Technologies Learning Objectives By the end of

slide-1
SLIDE 1

Prescriber Toolkit Presentation

The Care Transitions Network

National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart Technologies

slide-2
SLIDE 2

Learning Objectives

  • By the end of this webinar, attendees will understand:
  • Key steps for antipsychotic treatment planning
  • How to access, navigate, and use the online toolkits:
  • Clozapine Provider Toolkit
  • Long-Acting Injectable Provider Toolkit
slide-3
SLIDE 3

Introduction

  • Key factors in antipsychotic treatment planning:
  • Dosing
  • Duration of treatment
  • Adherence
  • LAIs prevent poor adherence
  • Clozapine works when others don’t
  • LAIs and clozapine are underutilized due to:
  • Prescriber discomfort
  • Difficulty obtaining these meds
  • Patient refusal
slide-4
SLIDE 4

Key Steps for Antipsychotic Treatment Planning

slide-5
SLIDE 5

First, confirm the diagnosis

For Schizophrenia-Spectrum disorders, diagnoses often change

slide-6
SLIDE 6

The chart diagnosis may not be accurate

We have individual trainings to help clinicians better diagnose psychotic disorders

slide-7
SLIDE 7

Next, choose an agent based on patient history

  • Is the patient in their first episode and antipsychotic naïve?
  • Is there a history of good response to an agent?
  • Is there history of poor tolerance to certain oral agents or preferences

based on side effect profile?

  • Is there history of medical co-morbidities (obesity, diabetes, metabolic

syndrome) that suggest use of one antipsychotic class over another?

  • Don’t neglect to offer an LAI
slide-8
SLIDE 8

An adequate trial of an antipsychotic is generally 6 weeks (except in special circumstances) A patient should have 2 suboptimal antipsychotic trials before their illness is considered treatment refractory One of these trials ideally should be with an LAI to rule out non-response due to poor adherence

Now, see if your trial works…

slide-9
SLIDE 9

After 2 failed trials, the next recommendation is clozapine It is important to give clozapine sufficient time to work (can expect positive response within 3 months, but trial of 1 year is appropriate) For suboptimal treatment with clozapine, ECT is recommended to augment treatment Using more than 1 antipsychotic does not work

What if standard treatment fails?

slide-10
SLIDE 10

Navigating Prescriber Toolkits

slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16
slide-17
SLIDE 17
slide-18
SLIDE 18
slide-19
SLIDE 19
slide-20
SLIDE 20
slide-21
SLIDE 21
slide-22
SLIDE 22
slide-23
SLIDE 23

Mark Complete

slide-24
SLIDE 24
slide-25
SLIDE 25
slide-26
SLIDE 26
slide-27
SLIDE 27
slide-28
SLIDE 28
slide-29
SLIDE 29
slide-30
SLIDE 30
slide-31
SLIDE 31
slide-32
SLIDE 32
slide-33
SLIDE 33
slide-34
SLIDE 34
slide-35
SLIDE 35
slide-36
SLIDE 36
slide-37
SLIDE 37
slide-38
SLIDE 38
slide-39
SLIDE 39
slide-40
SLIDE 40
slide-41
SLIDE 41
slide-42
SLIDE 42
slide-43
SLIDE 43
slide-44
SLIDE 44
slide-45
SLIDE 45
slide-46
SLIDE 46
slide-47
SLIDE 47
slide-48
SLIDE 48
slide-49
SLIDE 49
slide-50
SLIDE 50
slide-51
SLIDE 51
slide-52
SLIDE 52
slide-53
SLIDE 53
slide-54
SLIDE 54
slide-55
SLIDE 55
slide-56
SLIDE 56
slide-57
SLIDE 57
slide-58
SLIDE 58
slide-59
SLIDE 59
slide-60
SLIDE 60
slide-61
SLIDE 61
slide-62
SLIDE 62
slide-63
SLIDE 63
slide-64
SLIDE 64
slide-65
SLIDE 65
slide-66
SLIDE 66
slide-67
SLIDE 67
slide-68
SLIDE 68
slide-69
SLIDE 69
slide-70
SLIDE 70
slide-71
SLIDE 71
slide-72
SLIDE 72
slide-73
SLIDE 73
slide-74
SLIDE 74
slide-75
SLIDE 75

Next Steps

  • Care Transitions Networks will send you all a link to register
  • We encourage you to go through the curriculums
  • Review the archived recording of this webinar if you run into technical

difficulties

  • Spread the word to the prescribers and clinicians in your agencies
  • Forward them the registration link
  • Use clozapine for those with treatment refractory illness
slide-76
SLIDE 76

Lauren Hanna, M.D. LHanna1@northwell.edu The Zucker Hillside Hospital Northwell Health

The project described was supported by Funding Opportunity Number CMS-1L1-15-003 from the U.S. Department of Health & Human Services, Centers for Medicare & Medicaid Services. Disclaimer: The contents provided are solely the responsibility of the authors and do not necessarily represent the official views of HHS or any of its agencies.